Drug Database · Clinicians

Finasteride + Tamsulosin

Brands (1) TamplusShow all

Benign prostatic hypertropy drug combination (alpha-adrenoreceptor antagonist and testosterone-5-alpha reductase inhibitor) PH FDA category
Fixed-dose combination.

Rx · Prescription drug2 PH products
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: PROSCAR, is a 5α-reductase inhibitor, indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate t US FDA label

  • Use: Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies (14) ] . US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Sustained-release capsule: 200 mcg/5 mg, 400 mcg/5 mg

Registered products in the Philippines

2 products registered with the Food and Drug Administration (FDA) Philippines list Finasteride + Tamsulosin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Finasteride + Tamsulosin
Package insert
TamplusTamsulosin hydrochloride + Finasteride
200 mcg/5mg Sustained-Release CapsuleAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Ajanta Pharma LimitedIndia
Ajanta Pharma Philippines, Inc.
DR-XY38889
Dec 23, 2030
TamplusTamsulosin hydrochloride + Finasteride
400 mcg/5 mg Sustained-Release CapsuleAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Ajanta Pharma LimitedIndia
Ajanta Pharma Philippines, Inc.
DR-XY38883
Dec 23, 2030

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .